Cargando…
Use of High-Dose Chemotherapy in Front-Line Therapy of Infants Aged Less Than 12 Months Treated for Aggressive Brain Tumors
Introduction: Malignant brain tumors in infants less than 12 months of age are extremely rare, and they have poor prognosis. We evaluated genetic characteristics and response rates of infants with congenital brain tumors subjected to high-dose chemotherapy and autologous stem cell transplant after g...
Autores principales: | Guidi, Milena, Giunti, Laura, Buccoliero, Anna Maria, Santi, Mariarita, Spacca, Barbara, De Masi, Salvatore, Genitori, Lorenzo, Sardi, Iacopo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7160729/ https://www.ncbi.nlm.nih.gov/pubmed/32328470 http://dx.doi.org/10.3389/fped.2020.00135 |
Ejemplares similares
-
Case Report: A Case of Glioblastoma in a Patient With Haberland Syndrome
por: Ferranti, Silvia, et al.
Publicado: (2021) -
Pediatric High Grade Glioma Classification Criteria and Molecular Features of a Case Series
por: Buccoliero, Anna Maria, et al.
Publicado: (2022) -
Glioblastoma Chemoresistance: The Double Play by Microenvironment and Blood-Brain Barrier
por: Da Ros, Martina, et al.
Publicado: (2018) -
Bevacizumab-Irinotecan combination therapy in recurrent low-grade glioma, previously treated with chemo-radiotherapy: a case report
por: Castelli, Barbara, et al.
Publicado: (2023) -
A microRNA profile of pediatric glioblastoma: The role of NUCKS1 upregulation
por: Giunti, Laura, et al.
Publicado: (2019)